Waqas, Saad Ahmed
Imran, Zahra
Bilal, Abdur Rafay
Ahmed, Shahzaib
Gaba, Hateem
Chew, Nicholas W. S.
Greene, Stephen J.
Khan, Muhammad Shahzeb
Article History
Received: 6 June 2025
Accepted: 20 September 2025
First Online: 10 October 2025
Declarations
:
: Dr. Greene has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Otsuka, Pfizer, and Sanofi; has served on advisory boards or as consultant for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Corcept Therapeutics, Corteria Pharmaceuticals, CSL Vifor, Cytokinetics, Eli Lilly, Lexicon, Merck, Novo Nordisk, Otsuka, Roche Diagnostics, Sanofi, scPharmaceuticals, Sumitomo Pharma, and Tricog Health; and has received speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Lexicon, Novo Nordisk, and Roche Diagnostics. Dr. Khan has received fees from Bayer, Boehringer Ingelheim, and Novartis. All other authors have no conflicts of interest to declare.
: Not applicable.